Liver Transplant; ComplicationsLDLTNCT06542913
Left Lobe Versus Right Lobe in Adult Living Donor Liver Transplantation in Borderline GRWR
An observational study of Liver Transplant; Complications, run by Ain Shams University.
Trial summary
a prospective cohort study comparing outcomes of left lobe and right lobe adult living donor liver transplantation Read more about this study
- Who is it for?
- Ages 16 to 65 years
- Conditions the study is for
- Liver Transplant; Complications
- How many people
- 30 participants
- Where
- No sites listed yet
- Study dates
- 15 Sep 2024to 15 Jun 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 65 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: patients presented to our center for LDLT
Who may be able to join
- GRWR below 1
Who cannot join
- patients with renal impairment portal vein thrombosis vascular complications
Trial locations and contacts
No sites are listed yet.
About this study
Official title: Left Lobe Versus Right Lobe in Adult Living Donor Liver Transplantation in Borderline GRWR: Prospective Cohort Study
a prospective cohort study comparing outcomes of left lobe and right lobe adult living donor liver transplantation
- Conditions
- Liver Transplant; Complications
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| right lobe | cases underwent LDLT for right lobe with borderline GRWR | |
| left lobe | cases underwent LDLT for left lobe with borderline GRWR |
What is being measured
The primary outcome is the main question the study is designed to answer.
small for size syndrome
small for size syndrome
Measured: 1 year
Secondary outcomes (1)
other complications after LDLT
other complications after LDLT
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Aug 2024
- Study start15 Sep 2024 (estimated)
- Primary completion15 Jun 2026 (estimated)
- Study completion15 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Liver Transplant; ComplicationsStudies of the same condition, open and under way.
- More trials run by Ain Shams UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ain Shams University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06542913
- Sponsor's protocol ID
- ltvsrtldlt
- Other IDs
- Ain Shams University
- Acronym
- LDLT
- Status last verified
- Aug 2024
- First submitted
- 3 Aug 2024
- Last updated
- 7 Aug 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 7 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Left Lobe Versus Right Lobe in Adult Living Donor Liver Transplantation in Borderline GRWR: Prospective Cohort Study
- ClinicalTrials.gov ID
- NCT06542913
- Acronym / sponsor ID
- LDLT / ltvsrtldlt
- Conditions
- Liver Transplant; Complications
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Ain Shams UniversityUniversity, hospital or other
- Study start
- 15 Sep 2024 (estimated)
- Primary completion
- 15 Jun 2026 (estimated)
- Study completion
- 15 Jun 2026 (estimated)
- First posted
- 7 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
a prospective cohort study comparing outcomes of left lobe and right lobe adult living donor liver transplantation
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| right lobe | – | –cases underwent LDLT for right lobe with borderline GRWR |
| left lobe | – | –cases underwent LDLT for left lobe with borderline GRWR |
Who may qualify
- Ages
- 16 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- patients presented to our center for LDLT
Key inclusion criteria (1 listed)
- GRWR below 1
Key exclusion criteria (1 listed)
- patients with renal impairment portal vein thrombosis vascular complications
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
small for size syndrome
Time frame: 1 year
small for size syndrome
1 secondary outcome
other complications after LDLT
Time frame: 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Aug 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Liver Transplant; Complications
Not yet recruiting
New Biomarkers for Organ Viability Assessment During Hypothermic Machine Perfusion in Liver Transplantation: the Role of Extemporaneous Histological Examination.
Liver Transplantation (LT), Early Allograft Dysfunction
Active, not recruitingPhase 2
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Mucopolysaccharidosis Disorders, Hurler Syndrome
Recruiting
Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation
Liver Transplantation (LT), Ischemia-Reperfusion Injury
Not yet recruitingObservational study
Prospective Observational Multimodal Neuromonitoring During High-Risk Adult Surgery
Postoperative Cognitive Complications, Delirium
Not yet recruiting
Prophylactic Norepinephrine for Prevention of Acute Kidney Injury in Living-Donor Liver Transplantation
Noradrenaline
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Questions about this trial
What is this clinical trial studying?
An observational study of Liver Transplant; Complications, run by Ain Shams University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 7 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ibrahim Essam, M.Sc. MRCS (00201001805340, ibrahim.essam@med.asu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
small for size syndrome (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2024.